Covid-19: A Therapeutic Approach Based on Pathophysiological Staging

Research output: Contribution to journalArticleResearchpeer-review


The COVID-19 pandemic is a recently emerging problem. This has caused that the knowledge of the disease has been progressive and, therefore, the therapeutic decisions have been conditioned by this lack of knowledge on the one hand and by the therapeutic limitations on the other. Many published studies are methodologically weak and their conclusions, of limited value, have contributed to creating confusion on the therapeutic approach of the disease. In the present paper, we propose a therapeutic approach based on a new disease staging. The therapeutic approach is divided into two big sections: the pharmacological treatment for the phase of viral replication, cytokine storm or late respiratory events (which includes the adult respiratory distress syndrome (ARDS)) and the treatment of the respiratory failure In every stage, we discuss the pathophysiology and comment (accept or rule out) the pharmacological options according to the present evidence. Moreover, we indicate how respiratory failure should be treated. Some characteristics are based on the evidence found in the literature. Others are the result of my experience in other situations.

Original languageEnglish
Pages (from-to)32-37
Number of pages6
JournalOpen Respiratory Medicine Journal
Publication statusPublished - 2020


Dive into the research topics of 'Covid-19: A Therapeutic Approach Based on Pathophysiological Staging'. Together they form a unique fingerprint.

Cite this